By
Adrianne Appel2023-11-16T19:53:00
A nursing home chain and its owner agreed to pay $45.6 million in entering a consent judgment with the Department of Justice (DOJ) to resolve allegations employees paid kickbacks to doctors who brought patients to them.
Prema Thekkek and the six skilled nursing homes she owned through her company, Paksn, submitted false claims to Medicare, the DOJ alleged in a settlement agreement filed Wednesday in U.S. District Court for the Central District of California.
Thekkek and her facilities violated the Anti-Kickback Statute and the False Claims Act, the DOJ said.
2025-11-19T19:58:00Z By Adrianne Appel
A New Jersey and Midwest nursing home chain, and its former chief executive, must pay more than $146 million each for extensive health care fraud for engaging in widespread fraud related to Medicare and Medicaid.
2024-07-02T14:42:00Z By Adrianne Appel
A home health company operating in Indiana, Ohio, and Texas agreed to pay nearly $4.5 million to settle allegations it filed false claims by giving sports tickets and other kickbacks to assisted living facilities in exchange for referrals.
2024-01-11T21:50:00Z By Adrianne Appel
New Jersey-based clinical laboratory RDx Bioscience and its chief executive officer agreed to pay more than $13 million to the Department of Justice to settle illegal kickback allegations.
2025-11-19T19:18:00Z By Oscar Gonzalez
The release of thousands of emails written by Jeffrey Epstein has sparked a political storm. One Democratic Senator is ramping up pressure for the U.S. Treasury to also disclose the deceased financier’s bank records.
2025-11-19T14:10:00Z By Adrianne Appel
Horizon Blue Cross Blue Shield of New Jersey has agreed to pay $100 million to settle allegations that its 2020 contract with the state was fraudulent, according the state’s Attorney General.
2025-11-18T21:06:00Z By Jaclyn Jaeger
Foreign corruption enforcement relating to national security matters has been a common theme under the Trump administration. A second common theme continues to be the discrete way in which the DOJ has ended several FCPA investigations.
Site powered by Webvision Cloud